Fidopa 250 mg Tablet is a prescription medicine with the generic name methyldopa, used to treat high blood pressure. It belongs to a group of centrally acting antihypertensive drugs and works on the brain to lower blood pressure.
There are 7 brands of Methyldopa listed in Bangladesh. 1 of them has a lower unit price than Fidopa. The lowest listed price is Aldomet 250 mg Tablet at ৳ 1 per unit.
What is Fidopa 250 mg Tablet?
Fidopa 250 mg Tablet is made by Synovia Pharma PLC. and contains methyldopa, a centrally acting antihypertensive medicine. It is a prodrug, which means the body converts it into an active form that works on certain receptors in the brain to reduce nerve signals that tighten blood vessels. This helps lower blood pressure. It is a prescription-only tablet, so the doctor decides whether it suits a particular person, the dose and how long it is taken. People with liver disease, those taking MAO inhibitors, or anyone with a known allergy to the ingredients should speak to the doctor before use.
Uses of Fidopa
Fidopa 250 mg Tablet is used to treat hypertension, which means high blood pressure. It is a centrally acting sympatholytic antihypertensive medicine, so it acts through the nervous system to help bring blood pressure down. Because high blood pressure often has no obvious symptoms, the doctor will check progress and decide whether the medicine is working. Do not start, stop or change it on your own. Ask the doctor or pharmacist about how it fits into your overall blood pressure plan.
How to use Fidopa
Take Fidopa 250 mg Tablet exactly as the doctor prescribes. The doctor decides the dose, how often to take it and for how long. Swallow the tablet as directed, and do not change the amount yourself. If you miss a dose, ask the doctor or pharmacist what to do rather than doubling up. Because the medicine can cause drowsiness, especially early on or after a dose increase, be careful with driving or tasks needing alertness until you know how it affects you. Ask the pharmacist for any practical guidance.
Side effects of Fidopa
Some people feel drowsy, especially at the start of treatment or after a dose increase, and this usually settles. Headache, weakness or tiredness may also occur early on. Less common effects include dizziness on standing, slow heartbeat, swelling or weight gain, nausea, vomiting, diarrhoea, constipation, dry mouth and mood changes. Rarely, more serious problems with the liver, blood or heart have been reported. Tell the doctor promptly about ongoing drowsiness, swelling, fever, or yellowing of the skin or eyes.
Safety and precautions
Fidopa 250 mg Tablet must not be used by people with active liver disease such as acute hepatitis or active cirrhosis, by those who had a liver problem linked to methyldopa before, by anyone allergic to its ingredients, or by people taking MAO inhibitor medicines. Use with caution if you have had liver disease. Swelling or weight gain should be reported, and the medicine is not continued if swelling worsens or signs of heart failure appear. It is pregnancy category B and passes into breast milk, so pregnant or breastfeeding women should ask the doctor first. Always tell the doctor about other medicines, including iron supplements and lithium.
Frequently asked questions
What is Fidopa 250 mg Tablet used for, and what kind of medicine is it?
It is used to treat high blood pressure (hypertension). It is a centrally acting antihypertensive medicine, specifically a central sympatholytic, which works through the nervous system to help lower blood pressure. The doctor decides whether it is suitable for you and how it should be used.
Who should avoid Fidopa 250 mg Tablet or ask the doctor first?
Avoid it if you have active liver disease, a liver problem previously linked to methyldopa, an allergy to any ingredient, or if you take MAO inhibitor medicines. Ask the doctor first if you have had liver disease, are pregnant or breastfeeding, or take other medicines such as iron supplements or lithium.
What does the generic name methyldopa mean?
Methyldopa is the generic name of the active ingredient. It is a centrally acting sympatholytic and a prodrug, meaning the body changes it into an active form that acts on alpha-2 adrenergic receptors in the brain. This reduces nerve signals that narrow blood vessels, helping to lower blood pressure.
Can I stop Fidopa 250 mg Tablet on my own if I feel better?
No. High blood pressure often causes no symptoms, and stopping or changing the medicine on your own can be unsafe. The doctor decides the dose and course and will adjust it based on your progress. Speak to the doctor or pharmacist before making any change.
Methyldopa, or α-methyldopa, is a centrally acting sympatholytic agent and an antihypertensive agent. It is an analog of DOPA (3,4‐hydroxyphenylanine), and it is a prodrug, meaning that the drug requires biotransformation to an active metabolite for therapeutic effects. Methyldopa works by binding to alpha(α)-2 adrenergic receptors as an agonist, leading to the inhibition of adrenergic neuronal outflow and reduction of vasoconstrictor adrenergic signals. Methyldopa exists in two isomers D-α-methyldopa and L-α-methyldopa, which is the active form.
First introduced in 1960 as an antihypertensive agent, methyldopa was considered to be useful in certain patient populations, such as pregnant women and patients with renal insufficiency. Since then, methyldopa was largely replaced by newer, better-tolerated antihypertensive agents; however, it is still used as monotherapy or in combination with hydrochlorothiazide. Methyldopa is also available as intravenous injection, which is used to manage hypertension when oral therapy is unfeasible and to treat hypertensive crisis.
Dosage & Administration
Adults-
Initiation of Therapy: The usual starting dosage of Methyldopa is 250 mg two or three times a day in the first 48 hours. The daily dosage then may be increased or decreased, preferably at intervals of not less than two days, until an adequate response is achieved. To minimize the sedation, start dosage increases in the evening. When Methyldopa is given to patients on other antihypertensives, the dose of these agents may need to be adjusted to effect a smooth transition. When Methyldopa is given with antihypertensives other than thiazides, the initial dosage of Methyldopa should be limited to 500 mg daily in divided doses; when Methyldopa is added to a thiazide, the dosage of thiazide need not to be changed.
Maintenance Therapy: The usual daily dosage of Methyldopa is 500 mg to 2 g in two to four doses. Although occasional patients have responded to higher doses, the maximum recommended daily dosage is 3 gm. Occasionally tolerance may occur, usually between the second and third month of therapy. Adding a diuretic or increasing the dosage of Methyldopa frequently will restore effective control of blood pressure. A thiazide may be added at any time during Methyldopa therapy and is recommended if therapy'has not been started with a thiazide or if effective control of blood pressure cannot be maintained on 2 gm of Methyldopa daily. Methyldopa is largely excreted by the kidney and patients with impaired renal function may respond to smaller doses. Syncope in older patients may be related to an increased sensitivity and advanced arteriosclerotic vascular disease. This may be avoided by lower doses.
Pediatric Use: Initial dosage is based on 10 mg/kg of body weight daily in two to four doses. The daily dosage then is increased or decreased until an adequate response is achieved. The maximum dosage is 65 mg/kg or 3 gm daily, whichever is less.
Interaction
When Methyldopa is used with other antihypertensive drugs, potentiation of antihypertensive effect may occur. Patients may require reduced doses of anesthetics when on Methyldopa. When Methyldopa and lithium are given concomitantly the patient should be carefully monitored for symptoms of lithium toxicity. Coadministration of Methyldopa with ferrous sulfate or ferrous gluconate is not recommended.
Contraindications
Methyldopa is contraindicated in patients:
with active hepatic disease, such as acute hepatitis and active cirrhosis
with liver disorders previously associated with Methyldopa therapy
with hypersensitivity to any component of these products
on therapy with monoamine oxidase (MAO) inhibitors.
Side Effects
Sedation, usually transient, may occur during the initial period of therapy or whenever the dose is increased. Headache, asthenia, or weakness may be noted as early and transient symptoms. The following systemic side effects may rarely occur with the use of Methyldopa- angina pectoris, congestive heart failure, orthostatic hypotension, edema or weight gain, bradycardia, pancreatitis, colitis, vomiting, diarrhea, nausea, constipation, dryness of mouth, hyperprolactinemia, bone marrow depression, leukopenia, granulocytopenia, thrombocytopenia, hemolytic anemia; rheumatoid factor, hepatitis, jaundice, myocarditis, pericarditis, vasculitis, eosinophilia, parkinsonism, bell's palsy, nightmares and reversible mild psychoses or depression, dizziness, lightheadedness, paresthesias, arthralgia, myalgia, nasal stuffiness, rash, amenorrhea, gynecomastia, lactation, impotence. However, significant adverse effects due to Methyldopa have been infrequent and this agent usually is well tolerated.
Pregnancy & Lactation
Pregnancy category B. Methyldopa appears in breast milk. Therefore, caution should be exercised when Methyldopa is given to a nursing woman.
Precautions & Warnings
Methyldopa should be used with caution in patients with a history of previous liver disease or dysfunction. Some patients taking Methyldopa experience clinical edema or weight gain, which may be controlled by use of a diuretic. Methyldopa should not be continued if edema progresses or signs of heart failure appear. Hypertension has recurred occasionally after dialysis in patients given Methyldopa because the drug is removed by this procedure. Rarely involuntary choreoathetotic movements have been observed during therapy with Methyldopa in patients with severe bilateral cerebrovascular disease. If these movements occur, stop therapy
Overdose Effects
Acute overdosage may produce acute hypotension with other responses attributable to brain and gastrointestinal malfunction (excessive sedation, weakness, bradycardia, dizziness, lightheadedness, constipation, distention, flatus, diarrhea, nausea, vomiting). In the event of overdosage, symptomatic and supportive measures should be employed. When ingestion is recent, gastric lavage or emesis may reduce absorption. When ingestion has been earlier, infusions may be helpful to promote urinary excretion.
Storage Conditions
Do not store above 30°C. Keep out of the reach of children.
Alternative brands of Methyldopa
Other brands with the same generic name, cheapest first.